NeoGenomics

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The testing services offered by the Company’s laboratory include cytogenetics testing, which analyzes human chromosomes; Fluorescence In-Situ Hybridization (FISH) testing, which analyzes abnormalities at the chromosomal and gene levels; flow cytometry testing, which analyzes gene expression of specific markers inside cells and on cell surfaces; immunohistochemistry testing, which analyzes the distribution of tumor antigens in specific cell and tissue types, and molecular testing which involves analysis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) to diagnose and predict the clinical significance of various genetic sequence disorders. The testing services are utilized in the diagnosis, prognosis, and prediction for response to therapy of various types of cancers.